Journey Medical Corporation
DERM
$5.29
-$0.02-0.38%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.52% | 14.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.52% | 14.01% | |||
| Cost of Revenue | -19.20% | -4.03% | |||
| Gross Profit | 12.39% | 33.79% | |||
| SG&A Expenses | 10.34% | 22.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.46% | -23.09% | |||
| Operating Income | 1.13% | 70.99% | |||
| Income Before Tax | 28.89% | 67.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 28.89% | 67.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.89% | 67.81% | |||
| EBIT | 1.13% | 70.99% | |||
| EBITDA | 1.52% | 77.23% | |||
| EPS Basic | 30.76% | 68.19% | |||
| Normalized Basic EPS | -1.81% | 68.18% | |||
| EPS Diluted | 28.61% | 68.19% | |||
| Normalized Diluted EPS | -1.81% | 68.18% | |||
| Average Basic Shares Outstanding | 2.72% | 1.20% | |||
| Average Diluted Shares Outstanding | 2.72% | 1.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
